ArticleFrontiers in pharmacology2025
Deciphering metabolic disease mechanisms for natural medicine discovery via graph autoencoders.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic diseases, such as diabetes, pose significant risks to human health due to their complex pathogenic mechanisms, complicating the use of combination drug therapies. Natural medicines, which contain multiple bioactive components and exhibit fewer side effects, offer promising therapeutic potential. Metabolite imbalances are often closely associated with the pathogenesis of metabolic diseases. Therefore, metabolite detection not only aids in disease diagnosis but also provides insights into how natural medicines regulate metabolism, thereby supporting the development of preventive and therapeutic strategies. Deep learning has shown remarkable efficacy and precision across multiple domains, particularly in drug discovery applications. Building on this, We developed an innovative framework combining graph autoencoders (GAEs) with non-negative matrix factorization (NMF) to investigate metabolic disease pathogenesis via metabolite-disease association analysis. First, we applied NMF to extract discriminative features from established metabolite-disease associations. These features were subsequently integrated with known relationships and processed through a GAE to identify potential disease mechanisms. Comprehensive evaluations demonstrate our method's superior performance, while case studies validate its capability to reveal pathological mechanisms in metabolic disorders including diabetes. This approach may facilitate the development of natural medicine-based interventions. Our data and code are available at: https://github.com/Lqingquan/natural-medicine-discovery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.